A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

Completed · Phase 1

Conditions studied: Bladder Neoplasms, Carcinoma, Transitional Cell

In brief

Patients with superficial transitional cell carcinoma of the bladder will be treated with intravesical suramin in a phase I dose escalating study. The toxicity of suramin administered in this fashion will be evaluated.

Key facts

Study ID
NCT00001381
Run by
National Cancer Institute (NCI)
People needed
18
Starts
1994-03-01
Expected to finish
2000-12-01
Last updated by the study team
2008-03-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.